Abstract | BACKGROUND: METHODS: Fourteen patients with AKs in the face and scalp were included in this pilot study. Each patient had two fields randomly allocated to two different regimes: (i) continuing MAL incubation without prior curettage (-Cur) and (ii) 30 min MAL incubation after curettage (+Cur). The PpIX level in each field was measured with a hand-held fluorescence photometer every 30 min for 6 h after MAL application. No illumination was performed. RESULTS: The median PpIX level in the +Cur field after 3 h was 22 arbitrary units (AU), which represents the amount of PpIX that could have been photobleached after pulse- PDT with maximal treatment effect. After 3 h the median PpIX level in the -Cur field was 20 AU, which was not significantly different from the level in the +Cur field (p = 0.9). CONCLUSIONS: We propose PDT without curettage as follows: 3 h of MAL incubation and subsequently sufficient illumination. The treatment effect of this regime should be tested to verify if curettage of the face and scalp area may be omitted in PDT.
|
Authors | Ida M Heerfordt, Giedre Bieliauskiene, Hans Christian Wulf |
Journal | Photodiagnosis and photodynamic therapy
(Photodiagnosis Photodyn Ther)
Vol. 22
Pg. 155-157
(Jun 2018)
ISSN: 1873-1597 [Electronic] Netherlands |
PMID | 29601904
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Chemical References |
- Photosensitizing Agents
- Protoporphyrins
- methyl 5-aminolevulinate
- Aminolevulinic Acid
- protoporphyrin IX
|
Topics |
- Aged
- Aged, 80 and over
- Aminolevulinic Acid
(administration & dosage, analogs & derivatives, pharmacokinetics, therapeutic use)
- Curettage
- Face
- Female
- Humans
- Keratosis, Actinic
(drug therapy)
- Male
- Middle Aged
- Photochemotherapy
(methods)
- Photosensitizing Agents
(administration & dosage, pharmacokinetics, therapeutic use)
- Pilot Projects
- Protoporphyrins
(pharmacokinetics)
- Scalp
|